$0.33
Market Capitalization | 15.9M |
Book Value | $1.02 |
Earnings Per Share (EPS) | -0.12 |
Wall Street Target Price | 8.93 |
Profit Margin | -5.48% |
Operating Margin TTM | -11.23% |
Return On Assets TTM | -5.51% |
Return On Equity TTM | -492.08% |
Revenue TTM | 682.6M |
Revenue Per Share TTM | 15.55 |
Quarterly Revenue Growth YOY | 10.5% |
Gross Profit TTM | 355.6M |
EBITDA | -6.7M |
Diluted Eps TTM | -0.12 |
Quarterly Earnings Growth YOY | 12.19 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 2606.06%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 110.7M | ↑ 9.16% |
Net Income | -37.1M | ↑ 232.88% |
Net Profit Margin | -33.53% | ↓ 22.54% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 124.4M | ↑ 14.15% |
Net Income | 19.5M | ↓ 153.4% |
Net Profit Margin | 15.68% | ↑ 49.21% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 138.2M | ↑ 3.74% |
Net Income | -37.9M | ↓ 281.14% |
Net Profit Margin | -27.39% | ↓ 43.07% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 101.3M | ↓ 28.39% |
Net Income | -105.1M | ↑ 171.16% |
Net Profit Margin | -103.71% | ↓ 76.32% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 97.2M | ↑ 3.79% |
Net Income | -11.0M | ↓ 88.63% |
Net Profit Margin | -11.36% | ↑ 92.35% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 682.6M | ↑ 1.86% |
Net Income | -37.4M | ↓ 50.82% |
Net Profit Margin | -5.48% | ↑ 5.88% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | -24.1M | ↓ 196.43% |
Net Income | -6.8M | ↑ 4336.19% |
Net Profit Margin | 28.37% | ↑ 28.99% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 72.9M | ↓ 393.24% |
Net Income | -3.4M | ↓ 51.31% |
Net Profit Margin | -4.71% | ↓ 33.08% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 21.7M | ↓ 70.4% |
Net Income | 26.5K | ↓ 100.77% |
Net Profit Margin | 0.12% | ↑ 4.83% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 23.5M | ↑ 14.47% |
Net Income | -1.5M | ↓ 5901.65% |
Net Profit Margin | -6.2% | ↓ 6.32% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 181.6M | ↑ 6.58% |
Net Income | -13.7M | ↑ 29.53% |
Net Profit Margin | -7.53% | ↓ 1.33% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 181.6M | ↑ 0.0% |
Net Income | -13.7M | ↑ 0.0% |
Net Profit Margin | -7.53% | ↑ 0.0% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 98.4M | ↑ 17.05% |
Total Liabilities | 38.4M | ↓ 56.01% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 149.9M | ↑ 54.78% |
Total Liabilities | 65.4M | ↑ 72.91% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 159.2M | ↓ 0.86% |
Total Liabilities | 93.9M | ↑ 34.13% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 90.5M | ↓ 44.42% |
Total Liabilities | 119.8M | ↑ 24.66% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 79.2M | ↓ 5.3% |
Total Liabilities | 97.5M | ↓ 11.94% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 560.7M | ↑ 2.62% |
Total Liabilities | 527.0M | ↓ 21.6% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 80.3M | ↑ 0.46% |
Total Liabilities | 97.8M | ↓ 7.12% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 93.8M | ↑ 13.09% |
Total Liabilities | 87.5M | ↓ 13.42% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 79.5M | ↓ 15.54% |
Total Liabilities | 97.8M | ↑ 11.45% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 83.1M | ↑ 10.26% |
Total Liabilities | 78.7M | ↓ 15.13% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 560.7M | ↓ 6.93% |
Total Liabilities | 527.0M | ↓ 7.63% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 560.7M | ↑ 0.0% |
Total Liabilities | 527.0M | ↑ 0.0% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 711.6K | ↓ 93.64% |
Investing Cash Flow | -11.1M | ↑ 10.1% |
Financing Cash Flow | 9.7M | ↓ 336.78% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 12.4M | ↑ 1672.8% |
Investing Cash Flow | -16.3M | ↑ 49.87% |
Financing Cash Flow | 11.4M | ↑ 19.21% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -129.3K | ↓ 100.97% |
Investing Cash Flow | -19.5M | ↑ 11.56% |
Financing Cash Flow | 2.7M | ↓ 77.76% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 8.0M | ↓ 6160.62% |
Investing Cash Flow | -1.8M | ↓ 90.95% |
Financing Cash Flow | -7.1M | ↓ 355.61% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -10.9M | ↓ 247.04% |
Investing Cash Flow | 451.1K | ↓ 126.99% |
Financing Cash Flow | 6.6M | ↓ 200.7% |
Q3 FY19 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 0.0 | ↓ 100.0% |
Investing Cash Flow | 0.0 | ↓ 100.0% |
Financing Cash Flow | 0.0 | ↓ 100.0% |
Q4 FY19 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 5.9M | - |
Investing Cash Flow | 0.0 | - |
Financing Cash Flow | 10.8M | - |
Sell
Neutral
Buy
Aesthetic Medical International Holdings Group Ltd is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|
IDG Technology Venture Investment IV LLC
JPMorgan Chase & Co
Barclays PLC
Rhumbline Advisers
Renaissance Technologies Corp
Organization | Aesthetic Medical International Holdings Group Ltd |
Employees | 1286 |
CEO | Dr. Pengwu Zhou |
Industry | Health Services |
A Spac I Acquisition Corp
$0.33
+0.0%
Keyarch Acquisition Corp
$0.33
+0.0%
Connexa Sports Technologies Inc
$0.33
+0.0%
Us Value Etf
$0.33
+0.0%
First Wave Biopharma Inc
$0.33
+0.0%
Global X Msci Next Emerging
$0.33
+0.0%
Fat Projects Acquisition Corp
$0.33
+0.0%
Capital Link Global Fintech
$0.33
+0.0%
Applied Uv Inc
$0.33
+0.0%